Q32 Bio Inc.
QTTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $41,960 | $35,212 | $72,324 | $201,231 |
| - Cash | $77,965 | $39,266 | $43,893 | $32,247 |
| + Debt | $18,901 | $50,840 | $44,731 | $4,972 |
| Enterprise Value | -$17,104 | $46,786 | $73,162 | $173,956 |
| Revenue | $0 | -$6,651 | $6,651 | $33,971 |
| % Growth | 100% | -200% | -80.4% | – |
| Gross Profit | -$487 | -$6,651 | $6,651 | $24,427 |
| % Margin | – | 100% | 100% | 71.9% |
| EBITDA | -$45,300 | -$47,756 | -$38,855 | -$86,220 |
| % Margin | – | 718% | -584.2% | -253.8% |
| Net Income | -$47,733 | -$53,743 | -$42,809 | -$95,764 |
| % Margin | – | 808% | -643.6% | -281.9% |
| EPS Diluted | -6.58 | -16.7 | -13.42 | -12.23 |
| % Growth | 60.6% | -24.4% | -9.7% | – |
| Operating Cash Flow | -$67,715 | -$18,677 | -$10,957 | -$109,751 |
| Capital Expenditures | -$75 | -$5 | -$2,485 | -$2,396 |
| Free Cash Flow | -$67,790 | -$18,682 | -$13,442 | -$112,147 |